The research is important as currently 98 % of therapeutic molecules are also unable to cross the blood - brain barrier. (sciencedaily.com)
In theory, the input could be a molecular indicator of a disease, and the output could be an appropriate therapeutic molecule. (scientificamerican.com)
This immunoisolated micro-factory can remain in the tumor, providing a permanent and renewable source of therapeutic molecules for long - term cancer management.» (sciencedaily.com)